BridgeBio has substantially advanced its course of the new treatment for ATTR-CM, employing Attruby. Initial clinical information reveals significant benefits for those suffering from a severe condition. This effort highlights the company’s dedication to managing significant patient needs in this heart disease arena. Attruby: BridgeBio's Novel A